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Erasure and subsequent reinstatement of DNA methylation in the germline, especially at imprinted CpG islands
(CGIs), is crucial to embryogenesis in mammals. The mechanisms underlying DNA methylation establishment
remain poorly understood, but a number of post-translational modifications of histones are implicated in antago-
nizing or recruiting the de novo DNAmethylation complex. In mouse oogenesis, DNAmethylation establishment
occurs on a largely unmethylated genome and in nondividing cells, making it a highly informative model for ex-
amining how histone modifications can shape the DNA methylome. Using a chromatin immunoprecipitation
(ChIP) and genome-wide sequencing (ChIP-seq) protocol optimized for low cell numbers and novel techniques for
isolating primary and growing oocytes, profiles were generated for histonemodifications implicated in promoting or
inhibiting DNA methylation. CGIs destined for DNA methylation show reduced protective H3K4 dimethylation
(H3K4me2) and trimethylation (H3K4me3) in both primary and growing oocytes, while permissive H3K36me3 in-
creases specifically at these CGIs in growing oocytes. Methylome profiling of oocytes deficient in H3K4 demethy-
lase KDM1A or KDM1B indicated that removal of H3K4 methylation is necessary for proper methylation
establishment at CGIs. This work represents the first systematic study performing ChIP-seq in oocytes and shows
that histone remodeling in the mammalian oocyte helps direct de novo DNA methylation events.
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5-cytosine methylation—or DNA methylation—is a re-
pressive epigenetic mark that characterizes the majority
of CpGs within mammalian genomes. However, CpG-
dense regions called CpG islands (CGIs) are generally
unmethylated (Deaton and Bird 2011; Jones 2012). In
the male and female germlines, a number of CGIs com-
prise imprintedgermlinedifferentiallymethylated regions
(gDMRs), which acquire methylation in the germline and
retain this monoallelic methylation throughout develop-
ment and postnatal life (Sasaki and Matsui 2008). These
loci resist the genome-wide demethylation that occurs
following fertilization, and failure to establish ormaintain
methylation at imprinted gDMRs results in embryonic le-
thality (Kaneda et al. 2004; Smith andMeissner 2013). De-
spite its importance, the mechanisms responsible for
targeting DNA methylation to CGIs, especially in vivo,
remain poorly understood. However, it is known that
DNA methylation positively and negatively correlates
with a number of post-translational modifications of his-
tones, indicating that histone modifications may direct
theDNAmethyltransferase complex, including to certain
CGIs, during de novo events (Cheng and Blumenthal
2010; Blackledge and Klose 2011).
Starting from a largely unmethylated genome, ∼2000
CGIs gain methylation in mouse oocytes (Kobayashi et
al. 2012; Shirane et al. 2013), making oogenesis a biologi-
cally important system for epigenetic studies. It is also an
especially useful system, as only in oogenesis does epige-
netic reprogramming occur in the absence of replication,
meaning that de novo methylation events can be un-
coupled from the requirement for DNA methylation
maintenance between cell divisions (Smallwood and Kel-
sey 2012). This de novo methylation is concordant with
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oocyte growth, beginning in mice at around postnatal day
10 (P10) and largely finishing by P21, at the germinal ves-
icle (GV) stage (Obata and Kono 2002; Hiura et al. 2006;
Smallwood et al. 2011; Shirane et al. 2013). Transcription
is required formethylation at a number of gDMRs (Chota-
lia et al. 2009; Smith et al. 2011), and the oocyte methyl-
ome closelymirrors the oocyte transcriptome (Smallwood
et al. 2011; Kobayashi et al. 2012). Of the DNA methyl-
transferases DNMT1, DNMT3A, and DNMT3B and the
cofactor DNMT3L, DNMT3A and DNMT3L are primar-
ily required for methylation in the mouse oocyte, with
DNMT1 playing a subsidiary role in ensuring symmetric
methylation of CpG sites (Bourc’his et al. 2001; Hata et al.
2002; Kaneda et al. 2004; Smallwood et al. 2011; Shirane
et al. 2013).
How transcription might shape the oocyte methylome
remains unclear. Itmay simply render chromatinmore ac-
cessible to the DNMT3A/DNMT3L complex. However,
the parallels between histone modifications laid down
by transcription and histone modifications that correlate
or anti-correlate with DNA methylation in somatic con-
texts suggest that these marks may be the mechanism
through which transcription patterns the DNA methyl-
ome. Trimethylation and dimethylation of H3K4
(K4me3/K4me2) classically mark sites of transcription
initiation (Deaton and Bird 2011; Henikoff and Shilatifard
2011). More generally, K4me2 and K4me3 are hallmarks
of CGIs (Illingworth et al. 2008). H3K36 trimethylation
(K36me3), on the other hand, is associated with elongat-
ing eukaryotic chromatin (Kizer et al. 2005; Edmunds
et al. 2008; Yoh et al. 2008). Methylated H3K4 excludes
DNMT3A and DNMT3L via their ATRX–DNMT3A–
DNMT3L (ADD) domains, effectively protecting associat-
ed DNA from DNA methylation (Ooi et al. 2007; Noh
et al. 2015). Supporting the idea that K4me2/3 must be re-
moved from CGIs prior to de novo methylation, KDM1B
(AOF1), a K4me2 demethylase, is required for imprint es-
tablishment at several gDMRs in oocytes (Ciccone et al.
2010). Conversely, K36me3 can recruit both DNMT3A
(Dhayalan et al. 2010) and DNMT3B (Baubec et al. 2015;
Morselli et al. 2015). Since the majority of CGIs that ac-
quire methylation in the oocyte is intragenic (Smallwood
et al. 2011; Kobayashi et al. 2012), accumulation of
K36me3 may target these loci for DNA methylation.
To date, most of the analysis of the relationship be-
tween histone modifications and DNA methylation has
been done in systems such as mouse embryonic stem
(ES) cells or sperm owing to the relative ease of isolation
and large number of such cells available compared with
oocytes. Specifically, genome-wide chromatinmaps of de-
veloping mammalian oocytes have never been generated.
Here, we developed new methods to isolate primary oo-
cytes and growing oocyte nuclei by fluorescence-activated
cell sorting (FACS) followed by chromatin immunoprecip-
itation (ChIP) combined with sequencing (ChIP-seq) to
profile the dynamics of K4me2, K4me3, and K36me3 dur-
ing oogenesis. We also performed whole-genome bisulfite
sequencing on mature oocytes lacking the K4 demethy-
lase KDM1B or its paralog, KDM1A (LSD1), to determine
the extent of their roles in DNA methylation establish-
ment. We found that K36me3 specifically increases at
CGIs destined for DNAmethylation between the primary
and growing oocyte stage, in parallel with activation of
the upstream promoters that define the oocyte tran-
scriptome. K4me2 and K4me3 are relatively reduced but
largely static at these CGIs between embryonic day 18.5
(E18.5) and P10, but KDM1B-deficient and, to a lesser ex-
tent, KDM1A-deficient oocytes show loss of methylation
at CGIs, including at most imprinted gDMRs. This indi-
cates a step-wise modulation of CGI chromatin in which
K36me3 acquisition occurs prior to methylation estab-
lishment, and K4me2 removal occurs predominantly after
the onset of de novo methylation.
Results
Isolation of primary and growing oocytes for ChIP-seq
using novel FACS protocols
Oocytes are challenging to isolate in large numbers. The
most common collection method, picking by mouth pi-
petting from digested ovaries, is time-consuming and re-
turns 100–200 cells per mouse, making it unsuitable for
collecting the numbers of cells required for ChIP-seq. Ad-
ditionally, amassivewave of oocyte apoptosis begins from
around the time of birth in mice (Pepling 2006), making
the oocyte an increasingly rare cell in the ovary with in-
creasing age. To circumvent these issues, we developed
twomethods of oocyte isolation using FACS, which allow
us to process many mice in parallel in a relatively short
time. We concentrated on two time points in oogenesis:
The first, E18.5, represents the “ground state” of the oo-
cyte epigenome, as oocytes contain very little DNAmeth-
ylation (Smallwood et al. 2011; Shirane et al. 2013); at the
second, P10, de novo DNA methylation commences
(Tomizawa et al. 2012).
At E18.5, female germ cells have arrested in the diplo-
tene stage ofmeiosis I; are diploid, with 4NDNA content;
and can be considered primary, nongrowing oocytes. Oo-
cytes are also most numerous at this time point. Synapto-
nemal complex protein 3 (SYCP3) is a structural protein
that helps connect homologous chromosomes during
meiosis I (Handel and Schimenti 2010). At E18.5, oocytes
strongly express SYCP3 (Fig. 1A). We therefore developed
a FACS strategy based on SYCP3 staining and obtained, on
average, ∼3000 oocytes per E18.5 fetus using this method.
This strategy yielded pure oocyte populations for ChIP-
seq (Supplemental Fig. 1A).
E18.5 oocytes are small, measuring 10–20 μm in diame-
ter, and can readily be sorted by flow cytometry. Growing
oocytes, however, are ≥30–65 μm in diameter and cannot
be sorted intact. ChIP-seq requires only genomic DNA
and its associated proteins; therefore, we isolated nuclei
from P10 ovary preparations using a protocol adapted
from Rosner et al. (2013). Because all P10 oocytes are mei-
otically arrested, by staining the DNA and first gating on
the 4Npopulation, the small oocyte population in P10 nu-
cleus preparations could be more readily visualized (Fig.
1B, left panel). NOBOX, an oocyte-specific transcription
factor that characterizes oocytes in primordial follicles
Stewart et al.
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Figure 1. Development of oocyte FACS suitable for ChIP-seq. (A) FACS strategy for E18.5 primary oocyte isolation using SYCP3. (B)
FACS strategy for P10 growing oocyte nucleus isolation usingDNAcontent andNOBOX. (C ) Genome screenshots showing K4me3 signal
(as corrected read count) in E18.5 ovarian somatic cells, starting from 25,000, 10,000, or 5000 cells. The 5000-cell track represents grouped
biological replicates. Shown is a 1-kb windowwith a 1-kb step. (D) Peaks called in K4me3 ChIP-seqs starting from 25,000, 10,000, or 5000
cells show high agreement. The 5000-cell peaks were called from grouped biological replicates. (E) Replicate correlation over expected
enrichment sites (log-transformed corrected read count) in the E18.5 and P10 oocyte data sets: 4 kb centered on promoters for K4me2
and K4me3 and gene bodies for K36me3. CGI promoters are indicated by blue dots, and non-CGI promoters are indicated by red dots.
(F ) K4me2 and K4me3 signal (corrected read count) at the non-CGIOct4 and CGI Zp3 promoters reflects the silenced state of these genes
at E18.5 (top tracks) and active state at P10 (bottom tracks). Shown is a 100-base-pair (bp) windowwith a 100-bp step. (G) Trend plots show-
ing K4me2 and K4me3 signal (log-transformed corrected read count) over silent and active promoters (left panels; X-axis is in base pairs)
and K36me3 signal across their associated gene bodies (right panels) as determined by RNA sequencing (RNA-seq). (TSS) Transcription
start site; (TTS) transcription termination site.
GENES & DEVELOPMENT 2451
 Cold Spring Harbor Laboratory Press on December 7, 2015 - Published by genesdev.cshlp.orgDownloaded from 
(Suzumori et al. 2002; Rajkovic et al. 2004), is absent
at E18.5 but present in most SYCP3+ cells at P10 (Fig.
1B, right panel), effectively distinguishing primary and
growing oocytes. This FACS strategy yielded pure 4N,
NOBOX+ oocyte nuclei for ChIP-seq (Supplemental Fig.
1B,C). Using this method, ∼200 oocytes per mouse were
obtained, and, in our hands, up to 80 mice could be pro-
cessed in a single FACS sort, representing a significant ef-
ficiency improvement over mouth pipetting. Full gating
strategies for sorting E18.5 oocytes and P10 oocyte nuclei
are shown in Supplemental Figure 1D,E.
For this study, ChIP was carried out using the True
MicroChIP kit (Diagenode) with modifications (see the
Materials and Methods). E18.5 ChIP-seq was done on
25,000 cells per immunoprecipitation; P10 ChIP-seq
used the equivalent of 5000 cells per immunoprecipita-
tion. Before committing precious material, we performed
K4me3 ChIP-seq starting with 25,000, 10,000, or 5000
ovarian somatic cells, which showed high agreement in
each set when two biological replicates of 5000-cell
ChIP-seqs were merged (Fig. 1C,D). For the oocyte ChIP-
seq data sets, E18.5 and P10 replicates correlated well
over expected enrichment sites (Fig. 1E). Our protocol de-
tected K4me2 and K4me3 signal in oocytes at both CGI
promoters, such as that of Zp3, and non-CGI promoters,
such as Oct4, indicating that the resolution of the data
is sufficient for downstream analyses (Fig. 1F). Neither
of these genes is expressed at E18.5, and, accordingly,
K4me2/3 signal at these loci was greatly reduced at this
time point, indicating the purity of the isolated oocyte
populations. Looking genome-wide, enrichment of these
marks over gene bodies and transcription start sites
(TSSs) followed expected profiles at active and silent
promoters and active and silent genes (Fig. 1G). We there-
fore used these data sets to investigate distribution and en-
richment of these marks with regard to de novo DNA
methylation.
H3K4 methylation dynamics at CGIs destined
for DNA methylation
To investigate the role of H3K4 methylation at CGIs des-
tined to bemethylated or unmethylated in theGV oocyte,
we analyzed the ChIP-seq data sets for K4me2 and K4me3
from E18.5 and P10 oocytes. GV methylated (GVmeth)
CGIs and GV unmethylated (GVunmeth) CGIs were de-
fined using previously published data (Shirane et al.
2013). We first compared K4me2 and K4me3 at GVmeth
and GVunmeth CGIs within the same data set. CpG den-
sity is known to positively correlate with enrichment of
both K4me2 and K4me3 (Illingworth et al. 2010). Methyl-
ated CGIs in both the oocyte and somatic contexts tend to
be CpG-poor (Fig. 2A; Thomson et al. 2010; Krebs et al.
2014; Wachter et al. 2014). We therefore put CGIs into
subsets by CpG density to compare K4me2 and K4me3
enrichment in GVmeth and GVunmeth CGIs (Fig. 2B).
At both E18.5 and P10, there was a relative decrease in
both K4me2 and K4me3 in the GVmeth subset, and this
decrease became more significant with increasing CpG
density (Fig. 2B,C). This trend seems to be a general fea-
ture of these loci rather than oocyte-specific, as a similar
trend could be seen in 2i ES cells (Supplemental Fig. 2A;
Marks et al. 2012). Controlling for CpG density, GVun-
meth CGIs still showed higher H3K4 methylation at
both E18.5 and P10, indicating that CpG density alone
cannot account for the reduced H3K4 methylation levels
at GVmeth CGIs.
We next asked whether therewere any broad changes in
K4me2 or K4me3 enrichment at GVmeth CGIs between
E18.5 and P10. Enrichment for both K4me2 and K4me3
was relatively static between the two time points at these
loci, although a wide range of enrichments could be seen
among individual loci (Fig. 2D). Enrichment was also rel-
atively unchanged at thematernal imprinted gDMRs (Fig.
2D, black dots). Furthermore, the enrichment trends seen
in the GVmeth subset were mirrored in the GVunmeth
subset, indicating that GVmeth CGIs as a group are not
targeted for modulation of K4me2 or K4me3 between
E18.5 and P10.
Apart from CpG density, the other major determinant
of H3K4 methylation at CGIs is TSS activity (Henikoff
and Shilatifard 2011). To investigate the contribution of
CGI localization at E18.5 and P10 to H3K4 enrichment,
we divided CGIs into TSS, intragenic, and intergenic cat-
egories at each time point using RNA sequencing (RNA-
seq) data (Supplemental Table 1). The intergenic category
contained both intergenic CGIs and CGIs not associated
with an active gene at that time point. Unsurprisingly,
at both E18.5 and P10, a smaller proportion of GVmeth
CGIs were 5′-most TSSs (11.2% and 6.8%, respectively),
while a larger proportion of GVunmeth CGIs were
5′-most TSSs at both time points (∼46%) (Supplemental
Tables 2, 3). Because the majority of GVmeth CGIs and
all maternal imprinted gDMRs are intragenic at P10, we
focused on the GVmeth P10 intragenic category. As ex-
pected, CGIs that acted as TSSs at E18.5 had, on average,
more K4me2 and K4me3 than intragenic or intergenic
CGIs at that time point (Fig. 2E, top panels). However,
this relative enrichment persisted at P10 (Fig. 2E, bottom
panels), when these CGIs were all intragenic, suggesting
that the legacy of TSS activity was reflected in K4me2/3
enrichment at these loci. Retention of H3K4 methylation
could also be seen at imprinted gDMRs like Impact (TSS
at E18.5 and intragenic at P10) compared with others such
as Peg13 (intragenic at both E18.5 and P10) (Fig. 2F). Rela-
tively fewGVmeth CGIs were TSSs at E18.5 and intragen-
ic at P10 (102 of 1465 P10 intragenic CGIs), indicating that
this shift describes only aminority of GVmeth CGIs. This
indicates that K4me2 and K4me3 enrichment over
GVmeth CGIs at the onset of de novo DNA methylation
is influenced by their transcriptional state at E18.5, and
the majority of these CGIs are either intragenic or inter-
genic in the primary oocyte.
Growing oocytes show global H3K36me3 enrichment
and targeted H3K4me2/3 loss at GVmeth CGIs
We next investigated K36me3 dynamics between E18.5
and P10 at GVmeth CGIs. A greater proportion of
GVmeth CGIs was enriched in K36me3 at P10 compared
Stewart et al.
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Figure 2. H3K4 methylation dynamics at CGIs prior to de novo DNAmethylation. (A) Density plot of CpG densities of GVmeth (blue)
and GVunmeth (red) CGIs. (B) E18.5 and P10 K4me2 and K4me3 signal (log-transformed corrected read count) at 4 kb centered on CGIs,
separated into GVmeth and GVunmeth CGIs and by CpG density. (Black line) Median; (dashed lines) 1.5× interquartile range. (C ) Signifi-
cance of K4me2 or K4me3 enrichment difference between GVmeth and matched GVunmeth CGIs within each CpG density subset at
E18.5 and P10; unpaired one-sidedMann-Whitney test. (D) Scatter plots showing E18.5 versus P10 enrichment (log-transformed corrected
read count) for K4me2 (top panels) and K4me3 (bottom panels) in GVmeth and GVunmeth CGIs. (Black dots) Imprinted gDMRs. (E) His-
tograms showing K4me2 and K4me3 enrichment (log-transformed corrected read count) at GVmeth CGIs that are intragenic at P10, sep-
arated by annotation at E18.5. (Magenta) Intergenic; (light blue) intragenic; (dark blue) TSS. Dashed lines indicate the mean. (F ) Genome
screenshots showingChIP-seq signal (corrected read count) at E18.5 and P10 over thePeg13 and Impact imprinted gDMRs. Shown is a 100-
bp window with a 100-bp step.
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with GVunmeth CGIs (Fig. 3A). CGIs were generally de-
pleted of K36me3 with respect to flanking regions (Fig.
3B). CGIs tended to be K36me3-depleted irrespective
of localization or time point, with the exception of the
GVmeth subset of intragenic CGIs at P10, for which there
is no depletion of K36me3with respect to flanking regions
(Fig. 3B). This indicates that GVmeth CGIs that are intra-
genic at P10, which includes the majority of CGIs that
gain methylation in the oocyte, are relatively depleted of
K36me3 at E18.5 but preferentially enriched for K36me3
at the onset of de novo DNA methylation.
In our data, as has been observed by others, K36me3
levels correlate positively with transcription levels
(Supplemental Fig. 3A). To exclude the possibility that
the higher P10 K36me3 levels observed at GVmeth CGIs
were caused by higher expression of associated genes,
Figure 3. K36me3 is generally enriched, and K4me2/3 is depleted at certain GVmeth CGIs at P10. (A) Scatter plots showing E18.5 versus
P10 enrichment (log-transformed corrected read count) for K36me3 in GVmeth and GVunmeth CGIs. (Black dots) Imprinted gDMRs. (B)
Trend plots showing K36me3 signal (log-transformed corrected read count) at 4 kb centered on TSS, intragenic, and intergenic GVmeth
and GVunmeth CGIs as determined by RNA-seq at E18.5 and P10. (C ) Box plots showing K6me3 and H3 (log-transformed corrected read
count) at P10 intragenic GVmeth and GVunmeth CGIs, parsed by expression level. (Black line) Median; (dashed lines) 1.5× interquartile
range. (∗) P < 1 × 10−10; (∗∗) P < 1 × 10−25,Mood’smedian test. (D) Emission probabilities froma three-state segmentation of K4me2, K4me3,
and K36me3 E18.5 and P10 signal over CGIs. (E) Bar chart showing the proportion of protective, permissive, and unenriched CGIs in
GVmeth and GVunmeth CGIs at E18.5 and P10. (F ) K36me3, K4me2, and K4me3 enrichment (log-transformed corrected read count)
at 4 kb centered on GVmeth CGIs that transition from the protective to the permissive state between E18.5 and P10. (Black line) Median;
(dashed lines) 1.5× interquartile range. (∗) P < 1 × 10−10, Mood’s median test. (G) Genome screenshot showing ChIP-seq signal (corrected
read count) at E18.5 and P10 over the Zfp777 imprinted gDMR. Shown is a 100-bp window with a 100-bp step.
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intragenic GVmeth and GVunmeth CGIs were segregated
into expression quintiles based on the expression of the
gene in which they resided. As expected, a positive rela-
tionship between K36me3 level at intragenic CGIs and
expression could be seen (Fig. 3C, left panel); how-
ever, comparing GVmeth and GVunmeth CGIs within
the same quintile revealed consistent enrichment in the
GVmeth subset. This enrichment was not seen when
comparing K36me3 over the gene bodies (excluding the
CGIs) of the genes that contain these CGIs (Supplemental
Fig. 3B). Therefore, expression level alone does not explain
the elevated K36me3 levels at these CGIs. Nucleosome
density as measured by H3 ChIP-seq enrichment was
the same across all expression quintiles and methylation
categories (Fig. 3C, right panel). Unlike H3K4 methyla-
tion, K36me3 enrichment at CGIs is largely independent
of CpG density (Supplemental Fig. 3C). Taken together,
this suggests that some unidentified factor, and not nucle-
osome density, CpG density, or expression level, accounts
for the elevated K36me3 seen at the intragenic GVmeth
CGIs in growing oocytes.
To aggregate these data sets and characterize the com-
bined enrichment of K4me2, K4me3, and K36me3 at
CGIs at E18.5 and P10, ChIP signal at CGIs was analyzed
with unsupervised machine learning (ChromHMM)
(Ernst and Kellis 2012). Three states were found: one
that is enriched in K4me2 and K4me3 (state 1), one en-
riched in K36me3 (state 3), and one enriched for none of
these marks (state 2) (Fig. 3D). The unenriched state was
found to localize to CGIs with little or no ChIP signal,
and since state 2 CGIs appear in equal proportion in
GVmeth and GVunmeth CGIs at both time points
(Fig. 3E), they were not analyzed further. The K4me2/3-
enriched state 1 was termed the “protective state” and
the K36me3-enriched state 3 was termed the “permissive
state” to reflect the relationship between these respective
states and the properties of the de novoDNAmethylation
complex (Smallwood and Kelsey 2012).
Comparing the proportion of CGIs in each state, ∼60%
of GVmeth CGIs were in the permissive state at E18.5,
while the protective state characterized >70% of GVun-
meth CGIs at both time points (Fig. 3E). At both E18.5
and P10, the protective state characterized the majority
of TSS CGIs, while the permissive state characterized in-
tragenic CGIs (Supplemental Fig. 3D). Twelve percent
(244) of GVmeth CGIs transitioned from the protective
to the permissive state between E18.5 and P10, while
only 5% (1027) of GVunmeth CGIs made the same shift.
The majority of the GVmeth CGIs that made this shift
were intragenic at both time points (Supplemental Table
4). The GVmeth CGIs that transitioned from protective
to permissive were characterized by a modest increase
in K36me3 and a significant decrease in K4me2 between
E18.5 and P10 (Fig. 3F). These loci seemed to have lower
levels of K4me3 at both time points. It is important to
note, however, that because ChromHMM segregates the
genome into the number of states specified by the user,
loci with reasonably different combinations of marks
can be assigned the same state based on probability.
Therefore, a transition from the protective to the permis-
sive state between E18.5 and P10 could signify either an
increase in K36me3 or a decrease in K4me2 or K4me3.
Two imprinted gDMRs, Slc38a4 and Zfp777, also transi-
tioned from protective to permissive between E18.5 and
P10. At the Zfp777 locus, this transition appeared to be
driven by an increase of K36me3, as K4me2 and K4me3
are low at both time points (Fig. 3G). Taken together,
these results suggest that K36me3 enrichment is a general
feature of GVmeth CGIs between E18.5 and P10, while a
minority of GVmeth CGIs additionally loses H3K4 meth-
ylation during this time.
KDM1B is the primary H3K4me2 demethylase
required for CGI and imprinted gDMR methylation
in the oocyte
We observed enrichment of K4me2 and K4me3 at
GVmeth CGIs at both E18.5 and P10; however, before
these regions can be methylated, these marks may need
to be removed to facilitate recruitment of DNMT3A/3L.
To further investigate the role of H3K4 methylation
in DNA methylation establishment during oogenesis,
we conducted whole-genome bisulfite sequencing using
a low-cell post-bisulfite adaptor-tagging (PBAT) method
(Miura et al. 2012) on ovulated metaphase II (MII) oocytes
deficient in either KDM1A or KDM1B. Unbiased genome-
wide sliding window analysis identified 3425 hyperme-
thylated DMRs (hyperDMRs) and 7899 hypomethylated
DMRs (hypoDMRs) between controls and the KDM1A
knockout; in the KDM1B knockout, the overwhelm-
ing majority of all identified DMRs were hypomethy-
lated (45,102 of 45,187) (Supplemental Fig. 4A). DMRs in
both knockouts were primarily genic, especially among
KDM1B hypoDMRs, of which >90% were intragenic
with respect to the oocyte transcriptome (Supplemental
Fig. 4B). Assessing DNA methylation at CGIs in the
KDM1A knockout, 141 CGIs were hypermethylated and
360 were hypomethylated compared with the control (lo-
gistic regression, P < 0.05) (Fig. 4A, top). In the KDM1B
knockout, 893 CGIs showed methylation levels different
from those of the wild-type (logistic regression, P < 0.05);
the vastmajority of these CGIs (885) was hypomethylated
(Fig. 4A, bottom). None of the KDM1B hypermethylated
CGIs attained full (>75%) methylation; all eight were in-
termediately (25%–75%) methylated in the knockout
and unmethylated (<25%) in the control. Of the KDM1B
hypomethylated CGIs, eight were aberrantly hyperme-
thylated and 192 were hypomethylated in the KDM1A
data set (Supplemental Table 5; Supplemental Fig. 4C).
It therefore appears that the majority of GVmeth CGIs re-
quire KDM1B for proper methylation establishment, and
at least some CGIs require both KDM1A and KDM1B to
gain full DNA methylation.
We next asked how imprinted gDMRmethylation is af-
fected in the absence of KDM1A or KDM1B. In the
KDM1A knockout, all but two gDMRs, Gnas1A and
Cdh15, retained full methylation (≥75%) (Fig. 4B, top).
As has been observed previously, several gDMRs retain
full methylation in the KDM1B knockout oocyte; in our
data, these are Napl15, Zfp787, Inpp5f, and Cdh15 (Fig.
Histone modifications in DNA methylation
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4B, bottom). However, no gDMR was completely unme-
thylated in either the KDM1A or KDM1B knockout (al-
though Gnas1A, at 25.3% methylation, nearly met the
cutoff in the KDM1B knockout); instead, various levels
of intermediate methylation were observed at all compro-
mised gDMRs in the knockouts. This indicates that, like
GVmeth CGIs in general, imprinted gDMRs primarily
require KDM1B for methylation establishment, with
Figure 4. KDM1B, not KDM1A, predominantly affects CGI methylation. (A) Scatter plots showing methylation at CGIs in KDM1A-de-
ficient (top) and KDM1B-deficient (bottom) oocytes, compared with controls. (Blue dots) Significantly hypomethylated CGIs (hypoCGIs);
(red dots) significantly hypermethylated CGIs (hyperCGIs); (black dots) imprinted gDMRs; (WT) wild type; (CTRL)Kdm1aflox/+, ZP3-Cre-
control. (B) Bar plots showingmethylation levels at the 23maternally imprinted gDMRs in KDM1A-deficient (top) and KDM1B-deficient
(bottom) oocytes, compared with controls. (C ) Genome screenshots showing K4me2 ChIP-seq signal (as corrected read coverage) in E18.5
and P10wild-type oocytes and DNAmethylation over theGrb10,Gnas, andCdh15 gDMRs in normal and KDM1A- or KDM1B-deficient
MII oocytes. Shown is a 100-bp window with a 100-bp step. (D) Box plots showing E18.5 and P10 K4me2 (log-transformed corrected read
count) at 4 kb centered on CGIs that lose methylation in the absence of KDM1A, KDM1B, or both, compared with unaffected CGIs that
gain fullmethylation in theknockouts. (Black line)Median; (dashed lines) 1.5× interquartile range. (∗)P < 1 × 10−10; (∗∗)P < 1 × 10−25,Mood’s
median test. (E) Stacked bar plot depicting the proportion ofCGIs transitioning fromprotective to permissive states betweenE18.5 andP10
that losemethylation in the absence of KDM1A, KDM1B, or both. (Other) Either gainmethylation in the knockout or are intermediately/
unmethylated in the control. Shown are CGIs with adequate coverage in both the PBAT and the ChIP-seq data.
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KDM1A playing a minor role. The Grb10 gDMR, for ex-
ample, shows intermediate methylation in the KDM1B
knockout but full methylation in the KDM1A knockout
(Fig. 4C, left panel). TheGnas locus shows ∼74%methyl-
ation at theNespas-Gnasxl gDMRbut∼25%methylation
at the Gnas1A gDMR in the KDM1B knockout; Nespas-
Gnasxl and Gnas1A show 84% and 62% methylation,
respectively, in the KDM1A knockout (Fig. 4C, middle
panel). Cdh15 is the only uniquely compromised gDMR
in the KDM1A knockout; Gnas1A exhibits intermedi-
ate methylation in the absence of both KDM1A and
KDM1B, suggesting that it requires both to gain methyla-
tion (Fig. 4C, middle and right panels; Supplemental Ta-
ble 6). At all three loci, some loss of methylation within
the gene body can also be seen in the KDM1B knockout,
suggesting that KDM1B activity is important for proper
DNA methylation establishment along the entire tran-
scription unit. Strikingly, in the KDM1A knockout,
methylation has been lost along nearly the entire Cdh15
transcription unit, suggesting that loss of methylation
at the gDMR is a by-product of down-regulated Cdh15
transcription in the absence of KDM1A. Indeed, genic
hyperDMRs and hypoDMRs tended to be in genes that
show increased or decreased expression, respectively, in
the knockout, as assessed by RNA-seq on GV oocytes
(Supplemental Fig. 4D). In contrast, KDM1B hyperDMRs
and hypoDMRs showed no relationship with expression
of the associated gene. This suggests that KDM1A and
KDM1B play distinct roles within the oocyte: KDM1A
may act a transcription factor, and misregulated methyla-
tion in the KDM1A knockout is a consequence of misre-
gulated expression, while KDM1B demethylates K4me2
as part of the elongating RNA polymerase II (Pol II) com-
plex (Fang et al. 2010, 2013), and therefore the KDM1B
knockout shows severe hypomethylation but normal
gene expression.
Since KDM1A and KDM1B have beenmost extensively
characterized as K4me2-me0 demethylases, we compared
K4me2 enrichment at hypomethylated and unaffected
CGIs and gDMRs in our wild-type E18.5 and P10 ChIP-
seq data sets. For comparison, we also looked at K4me2
enrichment at CGIs hypomethylated in the absence of ei-
ther KDM1A or KDM1B and at CGIs unaffected by the ab-
sence of either protein. In all three comparisons, therewas
increased K4me2 at both time points in the CGIs that
fail to gain full methylation when compared with the
CGIs that gain methylation normally, but this was most
pronounced in the KDM1B knockout (Fig. 4D). Similarly,
the Grb10 and Gnas imprinted gDMRs are enriched with
K4me2 and show loss of methylation in the KDM1B
knockout, while the Cdh15 imprinted gDMR, whose
methylation is unaffected by loss of KDM1B, shows very
little K4me2 enrichment at E18.5 or P10 (Fig. 4C). This
indicates that KDM1B facilitates DNA methylation
establishment by removing K4me2 at the majority of
GVmeth CGIs and imprinted gDMRs and that CGIs unaf-
fected by the loss of KDM1B and, to a lesser extent,
KDM1A are constitutively in a permissive chromatin
state rather than targets of an alternative K4me2 deme-
thylation mechanism.
We then asked whether any CGIs hypomethylated in
the absence of KDM1AorKDM1B transition from the pro-
tective to the permissive state between E18.5 and P10.
Around 15% of E18.5 protective, P10 permissive CGIs
are also KDM1A hypomethylated or KDM1A/KDM1B
hypomethylated, while ∼60% of such CGIs (75) are hypo-
methylated in the KDM1B knockout (Fig. 4E). However,
no tangible change in K4me2 enrichment can be seen at
KDM1B hypomethylated CGIs as a whole between E18.5
and P10 (Fig. 4D, middle panel). Instead, this shift appears
to be driven by an increase in K36me3 and a decrease of
K4me2 specifically at the loci that transition from pro-
tective to permissive between E18.5 and P10, compared
with KDM1B hypomethylated CGIs that do not change
states (809) (Supplemental Fig. 4E). This further supports
the idea that H3K4me removal, perhaps facilitated by
KDM1B, occurs at specific loci prior to P10, but global
H3K4me removal atmostGVmethCGIs occurs sometime
after the onset of de novo DNAmethylation.
Discussion
Studies of the mammalian oocyte have been hindered by
the lack of high-throughput methods for their isolation.
Through the FACS approaches developed in this work,
molecular and genome-wide studies of the oocyte are
much more feasible. Beyond ChIP-seq, with the relevant
modifications, this approach could be used to study nucle-
osome positioning, three-dimensional chromatin con-
formation, chromosome accessibility, and a number of
other aspects of oocyte biology.
Using a low-cell ChIP method and focusing on histone
modifications implicated in influencing de novo DNA
methylation, our work reveals a step-wise modification
of the chromatin at CGIs destined for DNA methylation
in the mature oocyte (Fig. 5). Overall, although enrich-
ment in K36me3 and depletion of K4me2/3 are ultimate-
ly required as the permissive state for engagement of
DNMT3A/3L, the process and timing by which this state
is attained may differ among susceptible CGIs. This sug-
gests that there is not a single common mechanism of
CGI chromatin modulation downstream from the univer-
sal requirement for transcription in CGI methylation in
oocytes (Veselovska et al. 2015).
Our work shows that CGIs, even those foundwithin ac-
tive genes, are usually depleted of K36me3, amark of elon-
gating chromatin, but K36me3 increases specifically at
GVmethCGIs in parallel with the activation of the oocyte
transcriptome. Since K36me3 characterizes the transcrip-
tion units of active genes, this suggests one of two scenar-
ios: K36me3 is either habitually removed from intragenic
CGIs or habitually blocked from being established at
these loci. In ES cells, CGIs have been shown to be con-
stitutively depleted of K36me2 by KDM2A, which is
recruited to CGIs via its CXXC domain (Blackledge
et al. 2010). In vivo, the mammalian H3K36 trimethyl-
transferase SETD2 appears to work only from a dimethy-
lated template (Yuan et al. 2009), suggesting that depleted
K36me3 at CGIs is a consequence of depleted K36me2.
Histone modifications in DNA methylation
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Alternatively, KDM4A, a member of the only family of
lysine demethylases that can demethylate K36me3 (Klose
et al. 2006), has been shown to be recruited by K4me3
(Huang et al. 2006), suggesting that K4me3-depleted
CGIs (and many GVmeth CGIs are constitutively deplet-
ed in K4me3) may thus accumulate K36me3. More work
will need to be done to determinewhich scenario explains
the increased K36me3 seen at GVmeth CGIs in the grow-
ing oocyte.
Between E18.5 and P10, a subset of GVmeth CGIs also
loses protectiveK4me2/3. K4me2 loss can be attributed to
the activity of KDM1A and, in particular, KDM1B; how-
ever, the demethylases or mechanisms responsible for
K4me3 removal remain unknown. The requirement for
the KDM1A/KDM1B K4me2 demethylases implies that
K4me3 is removed at most oocyte methylated CGIs via
conversion to K4me2 rather than through a nucleosome
turnover/replacement mechanism. Several K4me3 deme-
thylases have been identified (Mosammaparast and Shi
2010), but which are active at oocyte methylated CGIs re-
mains unknown.
We detected an interesting difference in the effect of
KDM1A and KDM1B loss on the oocyte methylome:
KDM1A-deficient oocytes had similar numbers of aber-
rantly hypomethylated and hypermethylated CGIs, while
KDM1B-deficient oocytes had overwhelmingly hypome-
thylated CGIs. In addition, in the case of KDM1A, there
was a clear correlation between gene expression changes
and DNA methylation changes, a relationship that was
not apparent for loci that were differentially methylated
in the absence of KDM1B. KDM1A acts as a transcrip-
tional regulator in a number of other contexts (Metzger
et al. 2005; Macfarlan et al. 2011; Schenk et al. 2012;
Kerenyi et al. 2013). Our work suggests that many of
the KDM1A-dependent methylation differences at CGIs
are downstream from KDM1A-mediated transcriptional
changes and are not reflective of KDM1A K4me2 deme-
thylase activity. Instead, the K4me2 demethylase activity
of KDM1B, which is known to associate with the elongat-
ing Pol II complex (Fang et al. 2010, 2013), is directly re-
sponsible for the majority of hypomethylation events in
KDM1B-null oocytes (Supplemental Fig. 4F).
While K36me3 enrichment at oocyte methylated CGIs
was established prior to the onset of de novo methylation
at P10, K4me2/3 enrichment remained largely unchanged
between E18.5 and P10, which encapsulates the time at
which the oocyte transcriptome becomes active from ap-
proximately P5. This suggests that K4me2/3 removal is
not facilitated by transcriptional activity alone. Among
imprinted gDMRs, there are early methylating and late
methylating subsets (Obata and Kono 2002; Hiura et al.
2006), and it is possible that this asynchronicity extends
generally to CGIs that acquire methylation in oocytes.
Therefore, the propensity of a CGI to gain methylation
earlier or later in oogenesis may be a consequence of the
degree of K4me2/3 that it initially contains as well as
the timing of K4me2/3 removal. In somatic contexts,
CpG density and transcription factor binding, both of
which directly or indirectly enrich for K4me2/3, have
been shown to be instrumental in protecting CGIs during
de novo methylation (Krebs et al. 2014; Wachter et al.
2014). It may be that, in the oocyte, multiple rounds
of transcription and targeting are required to enrich
K36me3 and deplete K4me2/3 sufficiently to overcome




All experimental procedures were approved by the Animal
Welfare and Ethical Review Body at the Babraham Institute
and were performed under licenses issued by the Home Office
(UK) in accordance with the Animals (Scientific Procedures)
Act 1986. To isolate E18.5 primary oocytes, ovaries from
CD1 E18.5 fetuses were digested using 2 mg/mL collagenase







































Figure 5. Stepwisemodulation of CGI chromatin fa-
cilitates DNA methylation acquisition. At E18.5,
CGIs destined for DNA methylation are marked
with protective K4me2/K4me3 and lack permissive
K36me3. In parallel with postnatal activation of the
oocyte transcriptome, K36me3 accumulates specifi-
cally on CGIs destined for DNA methylation, and,
at P10, these CGIs are marked with both K4me2/
me3 and K36me3. During de novo DNAmethylation
between P10 and the GV stage, H3K4 methylation
from CGIs must be removed, as evidenced by the
methylation defects seen inmature oocytes in the ab-
sence of KDM1A and especially KDM1B.
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The reaction was stopped in 10% final volume of fetal bovine se-
rum (FBS) (Sigma, F7524) and filtered through a 50-µm mesh.
Cells were centrifuged at 1200 rpm for 5 min and incubated in a
1:1000 dilution of Live/Dead fixable dead cell stain (Thermo Sci-
entific, L23101) for 30 min, covered, at 4°C. Cells were washed in
FACS buffer (1× PBS, 1% FBS) and fixed in 1% formaldehyde
(Thermo Scientific, 28906) with 10%FBS for 10min at room tem-
perature followed by a 5-min quenchwith glycine (in TrueMicro-
ChIP kit, Diagenode). The cells were then incubated in a 1:1000
dilution of SYCP3 antibody (Abcam, ab97672) for 30 min, cov-
ered, at 4°C followed by incubation with secondary antibody
(Alexa fluor 647, donkey anti-mouse IgG). Antibody incubations
were done in permeabilization buffer (1× PBS, 1% FBS, 0.05%
Tween-20, 0.05% Triton-X).
Isolation of P10 oocyte nuclei was largely as described above.
Following CD1 ovary digestion, cells were not strained; instead,
nuclei were isolated as described by Rosner et al. (2013) except
that nowashes were done after cell membrane disruption. Nuclei
were then fixed using the samemethod as in E18.5 FACS. Nuclei
were incubated in a 1:200 dilution of NOBOX antibody (Abcam,
ab41521) for 30 min, covered, at 4°C followed by incubation with
secondary antibody (Alexa fluor 568, goat anti-rabbit IgG) and
DNA stain (Invitrogen, Hoechst 33342). All sorting was done on
a FACSAriaIII (Becton Dickinson).
Primary and growing oocyte RNA-seq
E18.5 oocytes used to extract RNA were collected using a proto-
col adapted from Pan et al. (2011). The protocol was as above, but
the FACS buffer used contained 1% BSA (Sigma, A2058) instead
of 1% FBS and, additionally, 100 U/mLRibolock RNase inhibitor
(Thermo Fisher, EO0381) and 5 mM DTT (from SuperScript first
strand synthesis system, Thermo Fisher, 11904-018). RNA from
sorted E18.5 oocytes was extracted using the RecoverAll total nu-
cleic acid isolation kit (Ambion/Thermo Scientific, AM1975) and
purified using the RNA Clean and Concentrator-5 kit (Zymo,
R1013) with on-column DNase treatment (RNase-free DNase I;
Thermo Scientific, AM2222). Ribosomal RNA was depleted
from total RNA using the Ribo-Zero magnetic kit (human/
mouse/rat, low input; Epicentre, SCL24G). To generate RNA-seq
libraries, RNAwas reverse-transcribed using SuperScript III (Life
Technologies, 18080044), with the second DNA strand synthe-
sized using dUTPs and DNA polymerase I (New England Biolabs,
M0210S). Libraries were constructed using theNEBNext DNA li-
brary preparationmaster mix set for Illumina (New England Biol-
abs, E6040S), with an additional step of dUTP excision by User
enzyme (New England Biolabs, M5505S) before PCR amplifica-
tion. Growing oocyte RNA-seq was taken from previously pub-
lished work (Veselovska et al. 2015).
ChIP-seq
Lysis and immunoprecipitation were performed using the True
MicroChIP kit (Diagenode, AB-002-0016) with the following
modifications. Up to 250,000 cells were sonicated in one lysate
and split into 25,000- or 5000-cell equivalents after sonication. Bi-
ological replicates were always derived from distinct lysates.
Samples were lysed using 25 µL of buffer tL1 and incubated for
5 min on ice. Seventy-five microliters of 1× Hank’s buffered salt
solution was added, and the lysate was sonicated in 1.5-mL
TPX microtubes (Diagenode). Chromatin was sheared using a
Bioruptor (Diagenode) with five active cycles (30 sec on, 30 sec
off). Sonicate was aliquoted, and an equivalent volume of com-
plete ChIP buffer tC1 was added. For immunoprecipitation, the
following antibodies and amounts of antibody were used for
both 25,000- and 5000-cell ChIP: 0.25 µg of H3K4me3 (Diage-
node, pAb-003-050), 0.25 µg of H3K4me2 (Abcam, ab32356),
5 µL of H3K36me3 (donated by Robert Klose), and 0.25 µg of H3
(Abcam, ab1791). Immunoprecipitation and washes were done
as described in the True MicroChIP protocol, with elution using
SPRI beads (1:1 ratio; Fisher Scientific, 09-981-123). ChIP-seq li-
braries were generated from immunoprecipitated DNA using
the NEBNext Ultra end repair/dA-Tailing module (E7742) fol-
lowed by SPRI purification (1:1 ratio) and 15–20 cycles of amplifi-
cation using Phusion polymerase (Thermo Scientific, F-530S)
before final purification using SPRI beads.
KDM1A/KDM1B MII oocyte collection
Experimentalmicewere used in accordancewith theNational In-
stitutes of Health Guide for the Care and Use of Laboratory Ani-
mals using institutional care and committee-approved protocols.
To disrupt KDM1A in oocytes, mice bearing the Kdm1a condi-
tional allele Lsd1fl (Kerenyi et al. 2013) were crossed with
ZP3-Cre transgenicmice. Lsd1fl/fl/ZP3-Cre+ femalemicewere re-
ferred to as KDM1A knockout; Lsd1fl/+/ZP3-Cre− female litter-
mates were used as controls. Generation of KDM1B knockout
(Aof11lox/1lox) mice was described previously (Ciccone et al.
2010), and wild-type littermates were used as controls. To obtain
MII oocytes, 6- to 8-wk-old mice were injected intraperitoneally
with 5 IU of pregnant mare’s serum gonadotrophin (PMSG)
(Sigma) and, 48 h later, 5 IU of human chorionic gonadotrophin
(hCG) (Sigma). Superovulated mice were euthanized 16 h after
hCG injection, and oocytes were collected from the oviducts
and released into a hyaluronidase/M2 solution for removal of cu-
mulus cells.
KDM1A/KDM1B PBAT
Genome-wide methylation maps in KDM1A- and KDM1B-defi-
cient MII oocytes and controls were generated using the PBAT
method (Miura et al. 2012) as adapted in Peat et al. (2014). For
each genotype, triplicate PBAT libraries were generated, each
from ∼100 MII oocytes. Each sample was spiked with ∼5 pg of
λ DNA to assess conversion efficiency, which was 98.7%–
99.2% for CpGs. Briefly, cells were lysed in EB buffer (Qiagen)
with 0.5% SDS (Sigma, 161-0418) and bisulfite-treated using
the one-step modification procedure in the Imprint DNAmodifi-
cation kit (Sigma,MOD50-1KT). The resultingDNAwas purified
using the EZ DNA methylation direct kit (Zymo, D5020). First
strand synthesis was performed using Klenow Exo− (New En-
gland Biolabs, M0212S) and a custom streptavidin-conjugated
adaptor containing standard Illumina adaptor sequences and 9
base pairs (bp) of random sequence (9N). This was followed by
exonuclease I treatment (New England Biolabs, M0293S), purifi-
cation using SPRI beads (1.8× ratio; Fisher Scientific, 09-981-
123), and binding to biotin beads (Life Technologies, 11205D).
Sampleswere then subjected to second strand synthesis, again us-
ing custom primer, followed by 10 cycles of library amplification
using Phusion polymerase (Thermo Scientific, F-530S) before fi-
nal purification using SPRI beads.
Library sequencing and mapping
All ChIP-seq, RNA-seq, and PBAT libraries were sequenced 100-
bp paired-end on an Illumina HiSeq1000. Raw reads were
trimmed to remove poor-quality calls and adapters using Trim-
Galore and mapped to the mouse genome (GRCm38 assembly).
ChIP-seq libraries weremapped using Bowtie1 “unique” parame-
ters; RNA-seq libraries were mapped using TopHat version 2.0.9
Histone modifications in DNA methylation
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(option –g 1). Paired-end PBAT libraries were mapped using Bis-
mark version 0.12.5 (options –pbat, –unmapped –bowtie2), any
unmapped reads were then mapped as single-end using Bismark
version 0.12.5 (read1 options: –bowtie2, –pbat; read2 options:
–bowtie2).
RNA-seq analysis
RNA-seq reads were assembled into E18.5 and growing oocyte
transcriptomes using Cufflinks (Trapnell et al. 2010; 2012). The
E18.5 transcriptome was assembled using Cufflinks version
2.1.1 with default parameters. The strategy for growing oocyte
transcriptome assembly has been described (Veselovska et al.
2015). For simplicity, the Ensembl reference gene annotation
was used to define silent and active promoters and their associat-
ed genes. A promoter or genewas considered active if it contained
at least one read and silent if it contained <0.001 reads. Only
genes that did not overlap with any other Ensembl gene annota-
tions were analyzed. CGI and maternal gDMR annotations
were from previously published data (Illingworth et al. 2010;
Tomizawa et al. 2011; Proudhon et al. 2012). CGIs were annotat-
ed as (1) a TSS if they overlapped the 5′-most TSS of a gene ±100
bp, (2) an alternative TSS if they overlapped any other TSS within
a gene ±100 bp, (3) intragenic if they overlapped a gene but were
not TSS-associated, and (4) intergenic if they did not overlap an
active gene. The true transcriptional activity of alternative
TSSs could not be confidently determined, so theywere discarded
from downstream analyses. CGIs on the Y chromosome were ex-
cluded from analysis.
ChIP-seq analysis
Sequencing and quality control details for each ChIP-seq library
are in Supplemental Table 7. All data sets were deduplicated prior
to analysis; 4 kb centered on each CGI or maternal gDMR was
used as the probe length for all relevant analyses. To excludemap-
ping artifacts, 10-kb nonoverlapping windows were tiled across
the genome and quantitated as raw read counts in E18.5 and
P10 H3 ChIP-seq data sets. Any window with a value more
than three times the median in either the E18.5 or P10 H3
ChIP-seq data set was considered an outlier. Any probe that over-
lapped by >5%of its lengthwith one of these outlierswas discard-
ed from all downstream analyses.
Peak calling was done essentially as described (Mikkelsen et al.
2010) with the following modifications: For each data set, raw
read counts were generated over 1-kb windows with a 100-bp
step, and the probabilities were generated for each window from
assuming a Poisson distribution with a mean equal to the expect-
ed number of ChIP reads given thewindow size, genome size, and
total number of aligned reads. Windows were not normalized to
an input control (H3 ChIP-seq at E18.5 and P10 was instead
used to filter out coverage outliers, see above). Windows with P
< 1 × 10−6 after Benjamini-Hochberg correction for multiple test-
ing were kept; overlapping windows were merged to generate the
final peak calls.
For all CGI and maternal gDMR comparisons, biological repli-
cates were first merged. All data were quantitated as follows:
Read counts for each time point were corrected to the largest
data store, one read was manually added to each probe, and
the data were log-transformed. To enable comparison between
ChIP data sets of the same histone mark at the two time points,
data sets were normalized to one another using a “multiply” cor-
rection to match values in each data set’s distribution at the 75th
percentile. All quantitation was done in Seqmonk version 0.32.0.
ChromHMM analysis
To compare chromatin at CGIs at E18.5 and P10, raw ChIP reads
from 4 kb centered on CGIs were used to generate a three-state
segmentation of the genome using ChromHMM (Ernst and Kellis
2012) using default parameters. E18.5 and P10 data sets were con-
sidered to originate from distinct cell types. To be designated as a
particular state, a CGI had to be covered along ≥80% of its length
by that state.
DNA methylation analysis
Sequencing and quality control details for each PBAT library are
in Supplemental Table 8. To filter out mapping artifacts, 25-kb
nonoverlapping windows were tiled across the genome as probes
and quantitated as read counts corrected to the largest data store.
Anywindowwith a value >10 times themedian in any PBAT data
set was considered an outlier and excluded from downstream
analyses. For theCGI and imprinted gDMRanalysis,methylation
was calculated as themean over eachCGI. To be included in anal-
ysis, a CGI ormaternal gDMRhad to have a least three CpGs cov-
ered by three or more reads; probes that did not meet coverage
requirements were discarded. Differentially methylated CGIs
were defined as those that passed a P < 0.05 threshold as calculat-
ed by logistic regression aftermultiple testing corrections, requir-
ing a methylation difference of ≥25% between knockout and the
appropriate control.
All data associated with this work have been deposited under
Gene Expression Omnibus accession numbers GSE73803 and
GSE74549.
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